Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Nucl Med Biol. 2012 Mar 22;39(7):926–932. doi: 10.1016/j.nucmedbio.2012.01.010

Table 2.

Immunohistochemistry results from the tumor specimens (patient numbers refer to table 1)

Patient Specimen Histology LAT1 IDO TPH1
intensity % positive intensity % positive intensity % positive
1. breast carcinosarcoma 3+ 100 2–3+ 100 n.a. n.a.
2. breast invasive micropapillary carcinoma 3+ 100 3+ 100 2–3+ 100
6. breast invasive ductal carcinoma 3+ 100 3+ 100 3+ 100
8. breast invasive ductal carcinoma 2–3+ 100 3+ 100 3+ 80
9. breast invasive ductal carcinoma 2–3+ 100 1–2+ 100 3+ 100
brain metastasis 2–3+ 100 2–3+ 100 1+ 100

Abbreviations LAT1: L-type amino acid transporter 1; IDO: indoleamine 2,3-dioxygenase; TPH1: tryptophan hydroxylase 1; staining intensity scores: 1+ = mild staining; 2+ = moderate staining; 3+ = strong staining; n.a.: no further specimen was available for staining.